Intelligence ยท Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors โ phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ searchable for business development and competitive intelligence.
-
Sodium tetradecyl sulfate
Hospital Authority, Hong Kong
Gastric Varices Bleeding
1 trial -
Somatostatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gallbladder Neoplasms
1 trial -
Sorafenib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatocellular Carcinoma
2 trials -
Sorafenib
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Standard First-Line Therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Unresectable Colorectal Cancer
1 trial -
Start antiplatelet monotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Intracerebral Hemorrhage
1 trial -
Steroid nasal spray
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation-Induced Mucositis
1 trial -
Subxiphoid uniportal VATS
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Mediastinal Neoplasms
1 trial -
Subxiphoid uniportal VATS
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Neoplasms
1 trial -
Supportive care+Prednisone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Minimal Change Disease
1 trial -
Suxiao Jiuxin Pill
The First People's Hospital of Lianyungang
Acute Mountain Sickness
1 trial -
Suzhou Scenerayยฎ DBS System
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Opiate Addiction
1 trial -
Systematic oral health education
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Malignant Tumor of Head and/or Neck
1 trial -
TCM
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-small Cell Lung Cancer
1 trial -
TNK-tPA
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
TPO
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sepsis
1 trial -
Tacrolimus
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Liver Transplantation
1 trial -
Tacrolimus
Hospital Authority, Hong Kong
Graft vs Host Disease
1 trial -
Tacrolimus capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Myasthenia Gravis
1 trial -
Tacrolimus capsules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lupus Nephritis
1 trial -
Tamoxifen
International Peace Maternity and Child Health Hospital
Breast Cancer
1 trial -
Tamoxifen
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer Female
1 trial -
Tang-min Lin pill
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 2 Diabetes
1 trial -
Taping and Sham Taping
Hospital Authority, Hong Kong
Stroke
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1โ3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources